Researchers demonstrated a MRI method sensitive to the live brain’s iron homeostasis (the r1-r2 extent of relaxation or relaxivity).
Donanemab Slows Progression in Early Alzheimer’s
AMSTERDAM — Investigational donanemab significantly slowed clinical progression at 76 weeks in people with early symptomatic Alzheimer’s disease who had amyloid and tau pathology, the
July 18, 2023